We are live on ! Find out more
JR

John Rogers Ariel Investments

AUM $10B
1-Year Est. Return 42.59%
 

John W. Rogers Jr. is the founder of Ariel Investments, one of the best-known minority-owned investment firms in the United States. Ariel is associated with patient, value-oriented investing and a long-term “slow and steady” culture. Rogers is also a prominent voice on markets, corporate leadership, and inclusive capitalism.

This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+42.59%
3 Year Est. Return
+78.13%
5 Year Est. Return
+79.56%
10 Year Est. Return
+301.99%
AUM
$8.2B
AUM Growth
+$57.8M
Cap. Flow
+$178M
Cap. Flow %
2.17%
Top 10 Hldgs %
27.54%
Holding
189
New
10
Increased
105
Reduced
65
Closed
7

Sector Composition

Rank Sector Weight
1 Financials 22.83%
2 Industrials 16.86%
3 Healthcare 12.56%
4 Communication Services 11.76%
5 Consumer Discretionary 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FICO icon
26
Fair Isaac
FICO
$25.3B
$103M 1.25%
1,856,845
-39,580
-2% -$2.19M
MDP
27
DELISTED
Meredith Corporation
MDP
$102M 1.25%
2,207,360
+132,341
+6% +$6.07M
LH icon
28
Labcorp
LH
$27.3B
$101M 1.23%
+1,196,167
New +$95.4M
NTRS icon
29
Northern Trust
NTRS
$33.6B
$98.6M 1.2%
1,503,441
+40,307
+3% +$2.5M
AFL icon
30
Aflac
AFL
$58.2B
$94.3M 1.15%
2,990,236
+71,106
+2% +$2.26M
STJ
31
DELISTED
St Jude Medical
STJ
$91.8M 1.12%
1,404,552
-199,919
-12% -$13M
ITW icon
32
Illinois Tool Works
ITW
$80.4B
$91.8M 1.12%
1,128,171
-81,474
-7% -$6.59M
BEN icon
33
Franklin Templeton, Inc.
BEN
$17.4B
$91.5M 1.12%
1,689,506
+208,146
+14% +$11.2M
BRC icon
34
Brady Corp
BRC
$4.3B
$90.3M 1.1%
3,325,294
+445,103
+15% +$12.5M
SSD icon
35
Simpson Manufacturing
SSD
$7.74B
$90.2M 1.1%
2,551,991
-53,345
-2% -$1.83M
ZBH icon
36
Zimmer Biomet
ZBH
$19.3B
$90.1M 1.1%
981,056
+24,433
+3% +$2.25M
OMC icon
37
Omnicom Group
OMC
$24B
$89.1M 1.09%
1,226,593
+232,059
+23% +$17.1M
MSGS icon
38
Madison Square Garden
MSGS
$9.78B
$88.4M 1.08%
2,181,599
-25,348
-1% -$1.04M
LFUS icon
39
Littelfuse
LFUS
$10.5B
$87.3M 1.07%
932,339
-69,535
-7% -$6.41M
DNB
40
DELISTED
Dun & Bradstreet
DNB
$87.1M 1.06%
876,852
+62,493
+8% +$6.58M
BYI
41
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
$82.8M 1.01%
+1,248,995
New +$89.5M
TPR icon
42
Tapestry
TPR
$26B
$78.3M 0.95%
1,576,003
+184,542
+13% +$9.19M
PARA
43
DELISTED
Paramount Global Class B
PARA
$78.3M 0.95%
1,266,360
-44,816
-3% -$2.83M
BID
44
DELISTED
Sotheby's
BID
$70.8M 0.86%
1,624,570
-45,716
-3% -$2.19M
CVSA
45
Covista Inc
CVSA
$4.51B
$70M 0.85%
1,650,729
-1,154,373
-41% -$44.7M
VIAB
46
DELISTED
Viacom Inc. Class B
VIAB
$69.2M 0.84%
814,169
-101,163
-11% -$8.61M
MHK icon
47
Mohawk Industries
MHK
$9.23B
$68.5M 0.84%
503,532
-64,620
-11% -$9.25M
MTSC
48
DELISTED
MTS Systems Corp
MTSC
$67M 0.82%
977,578
-25,996
-3% -$1.85M
TMO icon
49
Thermo Fisher Scientific
TMO
$233B
$66.9M 0.82%
556,094
-290,561
-34% -$34.5M
IEX icon
50
IDEX
IEX
$17.3B
$61.4M 0.75%
841,736
-274,678
-25% -$20M

Similar funds

John Rogers's Q1 2014 Portfolio in Review

As of Q1 2014, John Rogers held 189 positions worth $8.2B, up 0.71% from $8.14B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

John Rogers's Q1 2014 filing shows 10 new, 105 increased, 65 reduced and 7 closed positions. Its largest new stake was Labcorp: 1,196,167 shares worth $101M. The largest sale was Jones Lang LaSalle, an estimated $52.3M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.

  • John Rogers's largest Q1 2014 buy was Labcorp: 1,196,167 shares worth $101M.
  • John Rogers added most to J.M. Smucker in Q1 2014, an estimated $75.3M increase.
  • John Rogers's biggest Q1 2014 reduction was Jones Lang LaSalle, cutting an estimated $52.3M.
  • John Rogers fully exited Emergent Biosolutions in Q1 2014, selling an estimated $2.82M.
  • John Rogers's ten largest holdings make up 28% of its $8.2B portfolio in Q1 2014.
  • John Rogers opened 10 new positions and closed 7 in Q1 2014.
  • John Rogers's portfolio value rose 0.71% quarter-over-quarter to $8.2B.

Based on Ariel Investments's 13F filing for Q1 2014, filed 14 May 2014.